Literature DB >> 4522243

Swine vesicular disease: virological studies of experimental infections produced by the England-72 virus.

R Burrows, J A Mann, D Goodridge.   

Abstract

Pigs exposed to relatively small amounts of virus by intradermal inoculation of the feet or by skin sacrification developed clinical disease. Large amounts of virus were recovered from samples taken from the nose, mouth, pharynx, rectum and the prepuce or vagina during the first week of infection and smaller amounts during the second week. Virus was recovered from the faeces of most animals 16 days after infection and from one animal for 23 days. Pigs in contact with inoculated animals were killed at intervals before the appearance of clinical disease. The distribution and amounts of virus in various tissues indicated that infection has most likely gained entry through the skin or the epithelia and mucosae of the digestive tract. Some pigs acquired subclinical infections in which no virus excretion was detected and no transmission of infection to susceptible pigs took place over a period of 5 weeks.

Entities:  

Mesh:

Year:  1974        PMID: 4522243      PMCID: PMC2130259          DOI: 10.1017/s0022172400023305

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  6 in total

1.  Swine vesicular disease.

Authors:  R Burrows; A Greig; D Goodridge
Journal:  Res Vet Sci       Date:  1973-07       Impact factor: 2.534

2.  A preliminary investigation of the swine vesicular disease epidemic in Britain.

Authors:  P S Dawe; A J Forman; C J Smale
Journal:  Nature       Date:  1973-02-23       Impact factor: 49.962

3.  Differentiation of a vesicular disease of pigs in Hong Kong from foot-and-mouth disease.

Authors:  G N Mowat; J H Darbyshire; J F Huntley
Journal:  Vet Rec       Date:  1972-05-27       Impact factor: 2.695

4.  A foot and mouth disease syndrome in pigs caused by an enterovirus.

Authors:  L Nardelli; E Lodetti; G L Gualandi; R Burrows; D Goodridge; F Brown; B Cartwright
Journal:  Nature       Date:  1968-09-21       Impact factor: 49.962

5.  The infectivity assay of foot-and-mouth disease virus in pigs.

Authors:  R Burrows
Journal:  J Hyg (Lond)       Date:  1966-12

6.  The airborne excretion by pigs of swine vesicular disease virus.

Authors:  R F Sellers; K A Herniman
Journal:  J Hyg (Lond)       Date:  1974-02
  6 in total
  9 in total

1.  Experimental swine vesicular disease, pathology and immunofluorescence studies.

Authors:  R M Chu; D M Moore; J D Conroy
Journal:  Can J Comp Med       Date:  1979-01

2.  Residual viruses in pork products.

Authors:  P D McKercher; W R Hess; F Hamdy
Journal:  Appl Environ Microbiol       Date:  1978-01       Impact factor: 4.792

3.  Swine vesicular disease in Great Britain.

Authors:  W A Watson
Journal:  Can Vet J       Date:  1981-06       Impact factor: 1.008

4.  Molecular approach to the epidemiology of swine vesicular disease: correlation of variation in the virus structural polypeptides with serological properties.

Authors:  T J Harris; B O Underwood; N J Knowles; J R Crowther; F Brown
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

5.  Attemps to infect pigs with Coxsackie virus type B5.

Authors:  J M Garland; J A Mann
Journal:  J Hyg (Lond)       Date:  1974-08

6.  Swine vesicular disease: attempts to transmit infection to cattle and sheep.

Authors:  R Burrows; J A Mann; D Goodridge; W G Chapman
Journal:  J Hyg (Lond)       Date:  1974-08

7.  Swine vesicular disease: pathways of infection.

Authors:  J A Mann; G H Hutchings
Journal:  J Hyg (Lond)       Date:  1980-06

8.  Swine vesicular disease: comparative studies of viruses isolated from different countries.

Authors:  R Burrows; J A Mann; D Goodridge
Journal:  J Hyg (Lond)       Date:  1974-08

9.  Intestinal Viral Loads and Inactivation Kinetics of Livestock Viruses Relevant for Natural Casing Production: a Systematic Review and Meta-Analysis.

Authors:  Tinka Jelsma; Joris J Wijnker; Wim H M van der Poel; Henk J Wisselink
Journal:  Pathogens       Date:  2021-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.